Tag: PolyPeptide

Samsung Biologics, a leading South Korean CDMO that provides integrated services from discovery to commercial production, has entered into a definitive agreement to acquire Swiss listed PolyPeptide Group in a deal valuing the company at CHF 1.46bn (€1.57bn). PolyPeptide is a Swiss based specialist contract manufacturer of peptide based active pharmaceutical ingredients used by major pharmaceutical and biotechnology firms globally.…